Discontinuation report ZALTRAP
| Report ID | 121390 |
| Drug Identification Number | 02421089 |
| Brand name | ZALTRAP |
| Common or Proper name | AFLIBERCEPT solution |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | AFLIBERCEPT |
| Strength(s) | 200MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 8mL vial |
| ATC code | L01XX |
| ATC description | OTHER ANTINEOPLASTIC AGENTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2020-07-13 |
| Remaining supply date | 2016-07-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | last lot 3F007A, expiry 2016-07-31 |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: [email protected] Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2020-07-30 | French | Compare |
| v1 | 2020-07-30 | English | Compare |
Showing 1 to 2 of 2